Profiles in Pharma - March 22, 2017
“The scientist in me wants to make a difference”
After ten years of diabetes research and development at Novo Nordisk, Dorte X. Gram took her findings and work further to start something on her own. As founder and CEO of PILA PHARMA she hopes to bring a new oral anti-diabetic agent to the market. What made you take the leap to go on your […]
Profiles in Pharma - March 8, 2017
“We have to embrace the new era of diabetes care”
Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer at Novo Nordisk, talks about the Danish pharma giant’s drug-development strategy, the new era of diabetes care and his 25 year-long passion for his job. The changing diabetes market, with increasing competition and high prices for diabetes products in the US, has made the world’s […]
Profiles in Pharma - February 16, 2017
From regulator to pharma industry specialist
Dr. Thomas Lönngren, former head of the EMA and today a pharmaceutical consultant, provides some insights on the aftermath of Brexit, describes current challenges the industry is facing and takes a short walk down memory lane on his career journey. The summer of 2016 will be remembered for many things; record temperatures, terrorist acts in […]
Logistics - January 18, 2017
Reaching out
Two global life science firms share some of their projects and logistical solutions to deliver healthcare to parts of the world where it is needed the most. Cardiovascular disease is currently the third leading killer in Africa. Hypertension, one of the main risk factors for cardiovascular disease, is estimated to affect nearly half of adults […]
CMO - January 17, 2017
Surviving as a CMO
What are the key factors for survival as a CMO today? We have spoken to some Nordic CMOs to get an insight into the current possibilities and challenges. The pharmaceutical sector is undergoing some dramatic changes, with pipeline challenges, pricing pressures and emerging global markets reshaping the way that companies operate. The CMO marketplace has […]
Pharma article - November 30, 2016
New era for cancer diagnostics
Liquid biopsies, sequencing and upgraded software tools are among some of the recent and ongoing trends in cancer diagnostics. Developments in the diagnostic sector have vastly improved the ability to identify cancer diseases at the early stages of tumor formation. However, several cancer types cannot be identified early enough, while others may be recognized in […]
